U.S. Allstate, Mongodb, Primerica
Nov 26 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Allstate, Mongodb and Primerica on Tuesday.
HIGHLIGHTS
* Agilent Technologies Inc A.N: JP Morgan cuts target price to $160 from $165 |
* Allstate Corp ALL.N: Piper Sandler raises target price to $244 from $206 |
* Mongodb Inc MDB.O: Piper Sandler raises target price to $425 from $335 |
* Primerica Inc PRI.N: TD Cowen raises target price to $345 from $314 |
* UnitedHealth UNH.N: RBC raises target price to $655 from $595 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Agilent Technologies Inc A.N: JP Morgan cuts target price to $160 from $165 |
* Alector Inc ALEC.O: BTIG cuts target price to $5 from $16 |
* Alibaba Group BABA.N: JP Morgan cuts target price to $120 from $125 |
* Allstate Corp ALL.N: Piper Sandler raises target price to $244 from $206 |
* American Electric Power Company Inc AEP.O: JP Morgan cuts PT to $109 from $112 |
* Apogee Therapeutics APGE.O: Canaccord Genuity initiates coverage with buy rating; PT $89 |
* Applovin Corp APP.O: Jefferies raises target price to $400 from $270 |
* Avidity Biosciences RNA.O: RBC initiates coverage with outperform rating; PT $67 |
* Bath & Body Works Inc BBWI.N: Barclays raises target price to $34 from $28 |
* Bath & Body Works Inc BBWI.N: Jefferies raises target price to $39 from $34 |
* Bath & Body Works Inc BBWI.N: Piper Sandler raises target price to $36 from $35 |
* Bath & Body Works Inc BBWI.N: TD Cowen raises target price to $42 from $40 |
* Block Inc SQ.N: RBC raises target price to $110 from $88 |
* Bright Minds Biosciences DRUG.N: Baird initiates coverage with outperform rating and $75 PT |
* Centerpoint Energy CNP.N: JP Morgan raises target price to $34 from $32 |
* Central Garden & Pet Co CENT.O: Canaccord Genuity cuts target price to $45 from $48 |
* Cibus Inc CBUS.O: Jefferies cuts target price to $5 from $8 |
* Columbia Sportswear Co COLM.O: TD Cowen raises target price to $84 from $70 |
* Consolidated Edison Inc ED.N: JP Morgan cuts target price to $100 from $105 |
* Dominion Energy D.N: JP Morgan raises target price to $62 from $61 |
* Duke Energy Corp DUK.N: JP Morgan cuts target price to $125 from $128 |
* Dyne Therapeutics Inc DYN.O: RBC initiates coverage with outperform rating; PT $45 |
* Enanta Pharmaceuticals Inc ENTA.O: Baird cuts target price to $20 from $26 |
* Entergy ETR.N: JP Morgan raises target price to $172 from $151 |
* EQT Corp EQT.N: Truist Securities raises target price to $41 from $32 |
* Eversource Energy ES.N: JP Morgan cuts target price to $71 from $76 |
* Exelon Corp EXC.O: JP Morgan cuts target price to $42 from $44 |
* Exxon Mobil XOM.N: RBC cuts target price to $115 from $120 |
* Fiserv Inc FI.N: RBC raises target price to $255 from $224 |
* Goodrx Holdings Inc GDRX.O: JP Morgan cuts target price to $7 from $10 |
* Leslie's Inc LESL.O: Jefferies cuts target price to $3 from $3.25 |
* Merchants Bancorp MBIN.O: Piper Sandler raises target price to $52.5 from $48 |
* Moderna MRNA.O: JP Morgan cuts target price to $45 from $59 |
* Mongodb Inc MDB.O: Piper Sandler raises target price to $425 from $335 |
* Newmont NEM.N: Canaccord Genuity cuts target price to $60 from $63 |
* Newmont NEM.N: Jefferies cuts target price to $55 from $57 |
* Old National Bancorp ONB.O: KBW raises target price to $28 from $23 |
* Old National Bancorp ONB.O: Piper Sandler raises target price to $27 from $23 |
* Old National Bancorp ONB.O: RBC raises target price to $25 from $24 |
* ONEOK Inc OKE.N: JP Morgan raises target price to $120 from $103 |
* PayPal PYPL.O: RBC raises target price to $100 from $89 |
* PPG Industries Inc PPG.N: Berenberg cuts target price to $144 from $145 |
* PPL Corp PPL.N: JP Morgan raises target price to $38 from $37 |
* Primerica Inc PRI.N: TD Cowen raises target price to $345 from $314 |
* Public Service Enterprise Group Inc PEG.N: JP Morgan raises PT to $105 from $102 |
* Schneider National Inc SNDR.N: TD Cowen raises target price to $34 from $32 |
* Semtech Corp SMTC.O: Piper Sandler raises target price to $75 from $60 |
* Southern Co SO.N: JP Morgan raises target price to $92 from $91 |
* Summit Materials Inc SUM.N: D.A. Davidson raises target price to $52.5 from $47 |
* Teladoc Health Inc TDOC.N: JP Morgan raises target price to $13 from $9 |
* UnitedHealth UNH.N: RBC raises target price to $655 from $595 |
* Zoom Video Communications Inc ZM.O: Jefferies raises target price to $85 from $70 |
* Zoom Video Communications Inc ZM.O: Piper Sandler raises PT to $89 from $68 |
* Zscaler Inc ZS.O: Jefferies raises target price to $245 from $225 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
